INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 62 filers reported holding INHIBRX INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $563,418 | -37.0% | 30,704 | -10.8% | 0.00% | 0.0% |
| Q2 2023 | $893,985 | +35.1% | 34,437 | -1.8% | 0.00% | 0.0% |
| Q1 2023 | $661,733 | -19.5% | 35,068 | +5.1% | 0.00% | 0.0% |
| Q4 2022 | $822,089 | +44.5% | 33,364 | +5.3% | 0.00% | 0.0% |
| Q3 2022 | $569,000 | +57.6% | 31,678 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $361,000 | -20.8% | 31,765 | +55.1% | 0.00% | 0.0% |
| Q1 2022 | $456,000 | -54.9% | 20,480 | -11.6% | 0.00% | 0.0% |
| Q4 2021 | $1,011,000 | +33.0% | 23,158 | +1.5% | 0.00% | 0.0% |
| Q3 2021 | $760,000 | -28.2% | 22,823 | -40.7% | 0.00% | 0.0% |
| Q2 2021 | $1,059,000 | +328.7% | 38,485 | +213.1% | 0.00% | – |
| Q1 2021 | $247,000 | -39.0% | 12,292 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $405,000 | – | 12,292 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,023,325 | $11,615,000 | 3.23% |
| Opaleye Management Inc. | 590,000 | $6,697,000 | 3.02% |
| Sio Capital Management, LLC | 365,210 | $4,145,000 | 1.56% |
| Perceptive Advisors | 1,914,592 | $21,731,000 | 0.68% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 794,682 | $9,020,000 | 0.65% |
| Birchview Capital, LP | 70,448 | $800,000 | 0.58% |
| Meridian Wealth Advisors, LLC | 122,315 | $1,388,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 5,305,866 | $60,222,000 | 0.28% |
| ArrowMark Colorado Holdings LLC | 1,412,236 | $16,029,000 | 0.18% |
| Alaethes Wealth LLC | 19,341 | $220,000 | 0.16% |